Key result
Telmisartan provides effective blood pressure control, pleiotropic cardiovascular and renal benefits, and improves prognosis in patients with high cardiovascular risk.
Why the study?
Does telmisartan improve blood pressure control and reduce cardiovascular complications in patients with hypertension?
Does telmisartan improve blood pressure control and reduce cardiovascular complications in patients with hypertension?
Telmisartan is an effective antihypertensive agent with unique pharmacokinetic properties and pleiotropic effects that provide cardiovascular and renal protection.
Answers are grounded in this paper and cite their sources.
Supports telmisartan consideration in high-risk hypertension; leaves open head-to-head trials versus contemporary agents.
The current study describes pharmacological features and benefits of using the angiotensin II receptor blocker telmisartan in actual clinical practice. This bifunctional agent has a number of unique pharmacokinetic features: the longest duration of action, high lipophilicity and maximum efficiency in PPARy activation. The results of numerous studies confirmed the high efficacy of telmisartan and the ability to control blood pressure during the day and the early-morning hours compared to other antihypertensive drugs. The main pleutrophic effects of telmisartan have been proven at most stages of the cardiovascular and renal continuum, the main of which are a decrease in insulin resistance, an adiponectin levels increase, an improvement of endothelial function, angioprotective and renoprotective effects, and the regression of left ventricular hypertrophy. The ability of telmisartan to improve prognosis of patients with high cardiovascular risk and to reduce mortality and the number of cardiovascular complications has been proven. Based on the data of large-scale studies, the possibilities of using telmisartan (80 mg/day) were considered, including in combination with hydrochlorothiazide, as the most effective dual fixed-dose combination and one of the main modern antihypertensive strategies.
No takes yet. Share an insight, caveat, or question.
Sayutina et al. (2020) conducted a review in Hypertension. Telmisartan vs. Other antihypertensive drugs was evaluated. Telmisartan provides effective blood pressure control, pleiotropic cardiovascular and renal benefits, and improves prognosis in patients with high cardiovascular risk.
Synapse has enriched 10 related papers. Consider them for comparative context: